Serum lipid parameters and the prevalence of corneal arcus in a dyslipidaemic patient population

Cardiovascular Journal of South Africa

Volumn 15, Issue 4, 2004, Pages 166-169

  Meyer, D ^a   Liebenberg, P H ^a   Maritz, F J ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; CORNEA CURVATURE; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; SLIT LAMP; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ARCUS SENILIS; COHORT STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; MIDDLE AGED; PREVALENCE;

EID: 4944256989     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Sheraidah GAK, Winder AF, Fielder AR. Lipid-protein constituents of human arcus. Atherosclerosis 1998; 40: 91-98.
2. Winder AF. Factors influencing the variable expression of xanthelasmata and corneal arcus in familial hypercholesterolemia. Genet Eye Dis Birth Defects 1982; 18: 449-462.
3. Segal P, Insull W, Chambless LE, Stintett S, La Rosa JC, Weissfeld L. The association of dyslipoproteinemia with corneal arcus and xanthelasmata. Circulation 1986; I: 108-118.
4. Hoeg JM. Familial hypercholesterolemia. What the zebra can teach us about the horse. J Am Med Assoc 1994; 271: 543-546.
5. Rifkind BM, Dickerson C. The incidence corneal arcus in ischemic heart disease, it relation to serum lipid levels. Lancet 1965; I: 312-314.
6. Rosenman RH, Brand RJ, Scholtz RI, Jenkins CD. Relation of corneal arcus to cardiovascular risk factors and the incidence of coronary disease. N Engl J Med 1974; 291: 1322-1324.
7. Chambless LE, Fuchs FD, Linn S, Kritchevsky SB, Larosa JC, Segal PO. The association of corneal arcus with coronary disease and cardiovascular mortality in the lipid research clinics mortality follow-up study. Am J Public Health 1990; 80: 1200-1204.
8. Klein B, Klein R, Haseman J, Maready J, Harnes C. Corneal arcus and cardiovascular disease in Evans County, Georgia. Arch Intern Med 1975; 135: 509-511.
9. Rouhiainen P, Salonen R, Rouhiainen H, Salonen JT. Association of corneal arcus with ultrasonographically assessed arterial wall thickness and serum lipids. Cornea 1993; 12: 142-145.
10. Corneal arcus [editorial]. Lancet 1984; I: 376.
11. Thompson O. Clinical identification of high risk hyperlipidemia. In: Laker M, Neil A, Wood C, eds, Cholesterol Lowering Trials: Advice For the British Physician Royal College of Physicians, London: Gazelle Book Services; 1993: 33-44.
12. Winder AF, Jolleys JCW, Day LB and Butowski PF. Corneal arcus: case finding and definition of individual clinical risk in heterozygous familial hypercholesterolemia. Clin Genet 1998; 54: 497-502.
13. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, et al. HDL cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989; 79: 8-15.
14. Assmann G, Schulte H, von Eckardstein A, Huang Y. HDL cholesterol as a predictor of coronary heart disease risk: The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 1996; 124: S11-S20.
15. Lacko AG, Barter P, Ehnholm C, van Tol A. International symposium on basic aspects of HDL metabolism and disease prevention. J Lipid Res 2000; 41: 1695-1699.
16. Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by HDL plasma fraction in the cholesterol-fed rabbit. J Clin Invest 1990; 85: 1234-1241.
17. Benoit P, Emmanuel F, Caillaud JM, Bassinet L, Castro G, Gallix P. Somatic gene transfer of human apoA-1 inhibits atherosclerosis progression in mouse models. Circulation 1999; 99: 105-110.
18. Eriksson M, Carlson LA, Miettinen TA, Angelin B. Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I: Potential reverse cholesterol transport in humans. Circulation 1999; 100: 594-598.
19. Navab M, Hama SY, Cooke CJ, Anantharamaiah GM, Chaddha M, Lin G. Normal HDL inhibits three steps in the formation of mildly oxidzied LDL. J Lipid Res 2000; 41: 1481-1508.
20. Boas EP. Corneal arcus and atherosclerosis. J Mt Sinai Hosp 1945; 12: 79-83.
21. Wilcosky TC, Kwiterovich PO Jr, Glueck CJ, Suchindran CM, Laskarzewski P, Christensen B. Dyslipoproteinemia in black participants - The Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73: 119-125.
22. Hoogerbrugge N, Happee C, van Domburg R, Poldermans D, van den Brand MJ. Corneal arcus: indicator for severity of coronary atherosclerosis? Neth J Med 1999; 55: 184-187.
23. Friedlaender MH, Smolin G. Corneal degenerations. Ann Ophthalmol 1979; 11: 1485-1495.